Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2026-01-12 @ 9:41 AM
Study NCT ID:
NCT00855920
Status:
COMPLETED
Last Update Posted:
2017-04-28
First Post:
2009-02-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Utilizing Rilonacept in Gout Exacerbations
Sponsor:
Regeneron Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acute Gout Flare | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Metabolism, Inborn Errors | View |
| None | Allopurinol | View |
| None | Metabolic Diseases | View |
| None | Genetic Diseases, Inborn | View |
| None | Musculoskeletal Diseases | View |
| None | Joint Diseases | View |
| None | Arthritis | View |
| None | Rheumatic Diseases | View |
| None | Metabolic disorder | View |
| None | Purine-Pyrimidine Metabolism, Inborn Errors | View |
| None | Gout | View |
| None | Flare | View |